📋 Codes matching "Chromosome analysis"

Code Short Description Long Description
88230 CHROMOSOME ANALYSIS TISS CU TISSUE CULT NON-NEOPLAS PERIPH BLD
88230 HC CHROMOSOME ANALYSIS TISS CU
88230 CHROMOSOME ANALYSIS CULTURE WHOLE BLOOD LC 052019 PT.
88230 CHROMOSOME ANALYSIS INSTABILITY SYN TISSUE CULTURE
88237 CHROMOSOME ANALYSIS TISSUE CULTURE BONE MARROW GENZYME 130
88245 Chromosome analysis for breakage syndromes; baseline Sister Chromatid Exchange (SCE), 20-25 cells nan
88245 Chromosome analysis 20+AC0-25
88248 CHROMOSOME ANALYSIS INSTABILITY SYN BASELINE
88248 Chromosome analysis 50+AC0-100
88249 Chromosome analysis for breakage syndromes; score 100 cells, clastogen stress (eg, diepoxybutane, mitomycin C, ionizing radiation, UV radiation)
88249 CHROMOSOME ANALYSIS INSTABILITY SYN CLASTOGEN STRESS
88249 Chromosome analysis 100
88261 Chromosome analysis; count 5 cells, 1 karyotype, with banding
88261 TC CMA TAR LIM KARYO CVS, CHROMOSOME ANALYSIS, COUNT 5 CELLS, 1 KARYOTYPE, WITH BANDING
88261 TC CMA EXP LIM KARYO CVS, CHROMOSOME ANALYSIS, COUNT 5 CELLS, 1 KARYOTYPE, WITH BANDING
88261 HC NEO CHROMOSOME ANALYSIS;COUNT 5 CELLS,1 KARYOTYPE,W/ BANDING
88261 CHROMOSOME ANALYSIS 5
88262 CHROMOSOME ANALYSIS CNT 15 *CHROM ANALY PERIPH BLOOD
88262 HC CHROMOSOME ANALYSIS CNT 15
88262 CHROMOSOME ANALYSIS KARYOTYPE WHOLE BLOOD
88262 CHROMOSOME ANALYSIS KARYOTYPE WHOLE BLOOD RSL
88262 AMCH CHROMOSOME ANALYSIS 15 TO 20
88263 Chromosome analysis; count 45 cells for mosaicism, 2 karyotypes, with banding nan
88263 Chromosome analysis 45
88264 Chromosome analysis; analyze 20-25 cells
88264 CHROMOSOME ANALYSIS 20-25 CELL
88264 TC CHROMOSOME ANALYSIS, ANALYZE 20 TO 50 CELLS, CHROMT
88267 Chromosome analysis, amniotic fluid or chorionic villus, count 15 cells, 1 karyotype, with banding
88269 Chromosome analysis, in situ for amniotic fluid cells, count cells from 6-12 colonies, 1 karyotype, with banding
88269 CHROMOSOME ANALYSIS, IN SITU

ChargemasterDB by Joseph Paul Cohen
A database of US hospital prices based on data made available by the Centers for Medicare & Medicaid Services (CMS), HHS price transparancy rule 45 CFR §180.